ouabain has been researched along with mk 2206 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delamere, NA; Mandal, A; Shahidullah, M | 1 |
| Ami, HC; Beeri, R; Buzaglo, N; Golomb, M; Langane, F; Lichtstein, D; Pierre, S; Rosen, H | 1 |
2 other study(ies) available for ouabain and mk 2206
| Article | Year |
|---|---|
Src Family Kinase Links Insulin Signaling to Short Term Regulation of Na,K-ATPase in Nonpigmented Ciliary Epithelium.
Topics: Animals; Butadienes; Chromones; Ciliary Body; Enzyme Activation; Epithelium; Extracellular Signal-Regulated MAP Kinases; Heterocyclic Compounds, 3-Ring; Imidazoles; Insulin; Models, Biological; Morpholines; Nitriles; Ouabain; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Pigmentation; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Rubidium; Signal Transduction; Sodium-Potassium-Exchanging ATPase; src-Family Kinases; Sus scrofa; Time Factors | 2017 |
Augmentation of Ouabain-Induced Increase in Heart Muscle Contractility by Akt Inhibitor MK-2206.
Topics: Animals; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Heterocyclic Compounds, 3-Ring; Isolated Heart Preparation; Male; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Ouabain; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Ventricular Function, Left | 2019 |